Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

Jacob Lønborg; Henning Kelbæk; Niels Vejlstrup; Hans Erik Bøtker; Won Yong Kim; Lene Holmvang; Erik Jørgensen; Steffen Helqvist; Kari Saunamäki; Christian Juhl Terkelsen; Mikkel Malby Schoos; Lars Køber; Peter Clemmensen; Marek Treiman; Thomas Engstrøm

doi:10.1161/CIRCINTERVENTIONS.112.968388

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

Jacob Lønborg, Henning Kelbæk, Niels Vejlstrup, Hans Erik Bøtker, Won Yong Kim, Lene Holmvang, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Christian Juhl Terkelsen, Mikkel Malby Schoos, Lars Køber, Peter Clemmensen, Marek Treiman, Thomas Engstrøm

186 Citations (Scopus)

Abstract

Exenatide has been demonstrated to be cardioprotective as an adjunct to primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction (STEMI). The aim of the post hoc analysis study was to evaluate the effect of exenatide in relation to system delay, defined as time from first medical contact to first balloon.

Original language	English
Journal	Circulation. Cardiovascular interventions
Volume	5
Issue number	2
Pages (from-to)	288-95
Number of pages	8
ISSN	1941-7640
DOIs	https://doi.org/10.1161/CIRCINTERVENTIONS.112.968388
Publication status	Published - 2012

Keywords

Aged
Angioplasty
Chemotherapy, Adjuvant
Coronary Vessels
Disease-Free Survival
Electrocardiography
Female
Heart
Humans
Hypoglycemic Agents
Magnetic Resonance Imaging
Male
Middle Aged
Myocardial Infarction
Myocardium
Peptides
Reperfusion Injury
Venoms
Warm Ischemia

Access to Document

10.1161/CIRCINTERVENTIONS.112.968388

Cite this

Lønborg, J., Kelbæk, H., Vejlstrup, N., Bøtker, H. E., Kim, W. Y., Holmvang, L., Jørgensen, E., Helqvist, S., Saunamäki, K., Terkelsen, C. J., Schoos, M. M., Køber, L., Clemmensen, P., Treiman, M., & Engstrøm, T. (2012). Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circulation. Cardiovascular interventions, 5(2), 288-95. https://doi.org/10.1161/CIRCINTERVENTIONS.112.968388

Lønborg, J, Kelbæk, H, Vejlstrup, N, Bøtker, HE, Kim, WY, Holmvang, L , Jørgensen, E , Helqvist, S, Saunamäki, K, Terkelsen, CJ, Schoos, MM , Køber, L, Clemmensen, P, Treiman, M & Engstrøm, T 2012, 'Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia', Circulation. Cardiovascular interventions, vol. 5, no. 2, pp. 288-95. https://doi.org/10.1161/CIRCINTERVENTIONS.112.968388

@article{4ba4fdaa0444455cac2f67aa16daf434,

title = "Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia",

abstract = "Exenatide has been demonstrated to be cardioprotective as an adjunct to primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction (STEMI). The aim of the post hoc analysis study was to evaluate the effect of exenatide in relation to system delay, defined as time from first medical contact to first balloon.",

keywords = "Aged, Angioplasty, Chemotherapy, Adjuvant, Coronary Vessels, Disease-Free Survival, Electrocardiography, Female, Heart, Humans, Hypoglycemic Agents, Magnetic Resonance Imaging, Male, Middle Aged, Myocardial Infarction, Myocardium, Peptides, Reperfusion Injury, Venoms, Warm Ischemia",

author = "Jacob L{\o}nborg and Henning Kelb{\ae}k and Niels Vejlstrup and B{\o}tker, {Hans Erik} and Kim, {Won Yong} and Lene Holmvang and Erik J{\o}rgensen and Steffen Helqvist and Kari Saunam{\"a}ki and Terkelsen, {Christian Juhl} and Schoos, {Mikkel Malby} and Lars K{\o}ber and Peter Clemmensen and Marek Treiman and Thomas Engstr{\o}m",

year = "2012",

doi = "10.1161/CIRCINTERVENTIONS.112.968388",

language = "English",

volume = "5",

pages = "288--95",

journal = "Circulation. Cardiovascular interventions",

issn = "1941-7640",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

AU - Lønborg, Jacob

AU - Kelbæk, Henning

AU - Vejlstrup, Niels

AU - Bøtker, Hans Erik

AU - Kim, Won Yong

AU - Holmvang, Lene

AU - Jørgensen, Erik

AU - Helqvist, Steffen

AU - Saunamäki, Kari

AU - Terkelsen, Christian Juhl

AU - Schoos, Mikkel Malby

AU - Køber, Lars

AU - Clemmensen, Peter

AU - Treiman, Marek

AU - Engstrøm, Thomas

PY - 2012

Y1 - 2012

N2 - Exenatide has been demonstrated to be cardioprotective as an adjunct to primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction (STEMI). The aim of the post hoc analysis study was to evaluate the effect of exenatide in relation to system delay, defined as time from first medical contact to first balloon.

AB - Exenatide has been demonstrated to be cardioprotective as an adjunct to primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction (STEMI). The aim of the post hoc analysis study was to evaluate the effect of exenatide in relation to system delay, defined as time from first medical contact to first balloon.

KW - Aged

KW - Angioplasty

KW - Chemotherapy, Adjuvant

KW - Coronary Vessels

KW - Disease-Free Survival

KW - Electrocardiography

KW - Female

KW - Heart

KW - Humans

KW - Hypoglycemic Agents

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Myocardium

KW - Peptides

KW - Reperfusion Injury

KW - Venoms

KW - Warm Ischemia

U2 - 10.1161/CIRCINTERVENTIONS.112.968388

DO - 10.1161/CIRCINTERVENTIONS.112.968388

M3 - Journal article

C2 - 22496084

SN - 1941-7640

VL - 5

SP - 288

EP - 295

JO - Circulation. Cardiovascular interventions

JF - Circulation. Cardiovascular interventions

IS - 2

ER -

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

Abstract

Keywords

Access to Document

Fingerprint

Cite this